Currently Viewing:
Currently Reading
What We're Reading: NYC Expands Health Coverage; Hospital Transparency Rule Confusion; Eli Lilly Purchases Loxo Oncology
January 09, 2019 – AJMC Staff
Allowing HRAs for Short-Term Health Plans Would Undermine Markets, Insurers Say
January 02, 2019 – Allison Inserro
What We're Reading: ACA to Remain in Place During Appeal; Cigarette Ban in Pharmacies; Judge Blocks 340B Cuts
January 02, 2019 – AJMC Staff
Chemotherapy for Solid Tumors Associated With Increased Risk of AML, MDS
December 28, 2018 – Laura Joszt
This Year in Managed Care: 2018 Recap
December 28, 2018
Males With MPN Have More Aggressive Disease Biology, Independent of Other Factors
December 27, 2018 – Jackie Syrop
The Most-Read Articles From Evidence-Based OncologyTM for 2018
December 27, 2018 – Mary Caffrey
Challenges and Opportunities in the Oncology Care Model
December 23, 2018 – Laura Joszt
Diabetes, Cancer Interviews Among Most-Watched Videos of 2018
December 20, 2018 – Laura Joszt

What We're Reading: NYC Expands Health Coverage; Hospital Transparency Rule Confusion; Eli Lilly Purchases Loxo Oncology

AJMC Staff
New York City is expanding health coverage to 600,000 uninsured residents; a transparency rule requiring hospitals to post prices online is confusing patients; and Eli Lilly has purchased Loxo Oncology in what some are calling a massive bet on cancer genetic.

NYC Mayor Announces Universal Health Insurance Program

On Tuesday, New York City Mayor Bill de Blasio announced that the city will spend up to $100 million per year to cover 600,000 uninsured residents, including low-income residents and undocumented immigrants. According to the Associated Press, the plan involves expanding the city’s existing public insurance program—MetroPlus—and providing uninsured people with access to affordable care at city-owned facilities. It will also aim to provide these residents with a variety of services, ranging from primary care to mental health services, through the network of hospitals and clinics run by the city Health and Hospitals Corporation.


Rule Requiring Hospitals to Post Prices Online Is Confusing Patients

A rule starting January 1 required all hospitals to post their list prices online in an effort to boost transparency. However, according to Kaiser Health News, the new rule may be creating more confusion for patients, as the websites price lists—called chargemasters—are massive compendiums of prices set by each hospital for each service or drug. For a patient to figure out what an emergency visit might cost them, they must figure out and put together the price for each component of the visit, including blood tests, dispensed medications, and the facility fee.


Eli Lilly Purchases Loxo Oncology

Eli Lilly is expanding its oncology portfolio with its $8 billion purchase of Loxo Oncology, reported STAT. The purchase has been called a massive bet on cancer genetics, as Loxo Oncology’s medicines target genetic mutations regardless of where they are in the body. The drug maker’s first drug, Vitrakvi (larotrectinib) was approved in November 2018 for all solid tumors with an NTRK mutation, which exists in about 3% of cancer patients. Its second drug, LOXO-292, targets patients with lung of thyroid cancer with RET mutations.

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up